Have a feature idea you'd love to see implemented?
Let us know!
AEMD Aethlon Medical Inc
Price (delayed)
$0.3928
Market cap
$5.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.84
Enterprise value
-$2.85M
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier
Highlights
Aethlon Medical's EPS has increased by 30% YoY and by 21% QoQ
The company's debt fell by 7% QoQ
The company's equity has surged by 51% QoQ but it fell by 34% YoY
The quick ratio has grown by 42% from the previous quarter but it has contracted by 40% YoY
Aethlon Medical's gross profit has shrunk by 100% YoY
AEMD's revenue has plunged by 100% YoY
Key stats
What are the main financial stats of AEMD
Market
Valuations
Earnings
Shares outstanding
13.94M
Market cap
$5.47M
Enterprise value
-$2.85M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.63
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$11.5M
EBITDA
-$11.14M
Free cash flow
-$9.42M
Per share
Balance sheet
Liquidity
EPS
-$3.84
Free cash flow per share
-$1.26
Book value per share
$0.63
Revenue per share
$0
TBVPS
$1.53
Total assets
$11.42M
Total liabilities
$2.7M
Debt
$869,945
Equity
$8.71M
Working capital
$7.42M
Debt to equity
0.1
Current ratio
4.49
Quick ratio
4.32
Net debt/EBITDA
0.75
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-107.1%
Return on equity
-141.9%
Return on invested capital
-861.3%
Return on capital employed
-123.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AEMD stock price
How has the Aethlon Medical stock price performed over time
Intraday
-1.06%
1 week
-8.88%
1 month
5.85%
1 year
-78.06%
YTD
-82.06%
QTD
-15.78%
Financial performance
How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.85M
Net income
-$11.5M
Gross margin
N/A
Net margin
N/A
Aethlon Medical's gross profit has shrunk by 100% YoY
AEMD's revenue has plunged by 100% YoY
The net income has increased by 7% year-on-year and by 6% since the previous quarter
The company's operating income rose by 6% QoQ and by 4.5% YoY
Growth
What is Aethlon Medical's growth rate over time
Valuation
What is Aethlon Medical stock price valuation
P/E
N/A
P/B
0.63
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has increased by 30% YoY and by 21% QoQ
The P/B is 52% below the 5-year quarterly average of 1.3 and 10% below the last 4 quarters average of 0.7
The company's equity has surged by 51% QoQ but it fell by 34% YoY
AEMD's revenue has plunged by 100% YoY
Efficiency
How efficient is Aethlon Medical business performance
The ROE has plunged by 87% YoY and by 7% from the previous quarter
The ROA has plunged by 66% YoY and by 3.8% from the previous quarter
Aethlon Medical's ROIC has decreased by 40% YoY and by 9% from the previous quarter
Dividends
What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AEMD.
Financial health
How did Aethlon Medical financials performed over time
The quick ratio has grown by 42% from the previous quarter but it has contracted by 40% YoY
Aethlon Medical's current ratio has decreased by 39% YoY but it has increased by 32% QoQ
The company's debt is 90% lower than its equity
The company's equity has surged by 51% QoQ but it fell by 34% YoY
The debt to equity has increased by 43% year-on-year but it has declined by 38% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.